Related Experiment Video
Updated: Jun 22, 2025
A Net Mold-based Method of Scaffold-free Three-Dimensional Cardiac Tissue Creation
Published on: August 5, 2018
Development of advanced cardiac progenitor cell culture system through fibronectin and vitronectin derived peptide
Na Kyung Lee1, Woong Bi Jang1, Dong Sik Seo2
1Laboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan 50612, Korea; Convergence Stem Cell Research Center, Pusan National University, Yangsan 50612, Korea.
Insights
Bioengineered plates enhance human cardiac progenitor cell (hCPC) function. This approach supports stem cell therapy for cardiovascular disease by improving cell adhesion, proliferation, and delaying senescence.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Cardiovascular Research
Background:
- Cardiovascular disease is a significant global health issue.
- Human cardiac progenitor cells (hCPCs) offer therapeutic potential but face limitations like availability and senescence.
- Current stem cell therapies for cardiac repair require improved cell maintenance and expansion methods.
Purpose of the Study:
- To develop a bioengineered cell culture system that mimics the cardiac tissue microenvironment.
- To enhance the functionality and longevity of human cardiac progenitor cells (hCPCs) for therapeutic applications.
- To investigate the impact of extracellular matrix (ECM) peptide motifs and mussel adhesive protein (MAP) on hCPC behavior.
Main Methods:
- A novel cell culture plate was engineered by coating with specific extracellular matrix (ECM) peptide motifs (fibronectin and vitronectin) and mussel adhesive protein (MAP).
- The performance of these engineered plates (Fibro-P and Vitro-P) was evaluated by culturing hCPCs and comparing their adhesion, proliferation, migration, and differentiation against uncoated controls.
- Cellular senescence and stemness were assessed during long-term culture on the coated plates.
Main Results:
- Fibro-P and Vitro-P coated plates significantly enhanced hCPC adhesion, proliferation, migration, and differentiation compared to uncoated plates.
- Long-term culture on the engineered plates effectively delayed cellular senescence and preserved hCPC stemness.
- These improvements were linked to the activation of integrin downstream signaling pathways.
Conclusions:
- Engineered ECM peptide motif-MAP-coated plates provide a supportive microenvironment for hCPCs.
- This bioengineered approach shows promise for improving the therapeutic efficacy of stem cell-based treatments in cardiac tissue engineering.
- The findings support the development of advanced biomaterials for regenerative medicine applications in cardiovascular repair.
Abstract:
Cardiovascular disease remains a global health concern. Stem cell therapy utilizing human cardiac progenitor cells (hCPCs) shows promise in treating cardiac vascular disease. However, limited availability and senescence of hCPCs hinder their widespread use. To address these challenges, researchers are exploring innovative approaches. In this study, a bioengineered cell culture plate was developed to mimic the natural cardiac tissue microenvironment. It was coated with a combination of extracellular matrix (ECM) peptide motifs and mussel adhesive protein (MAP). The selected ECM peptide motifs, derived from fibronectin and vitronectin, play crucial roles in hCPCs. Results revealed that the Fibro-P and Vitro-P coated plates significantly improved hCPC adhesion, proliferation, migration, and differentiation compared to uncoated plates. Additionally, long-term culture on the coated plates delayed cellular senescence and maintained hCPC stemness. These enhancements were attributed to the activation of integrin downstream signaling pathways. The findings suggest that the engineered ECM peptide motif-MAP-coated plates hold potential for enhancing the therapeutic efficacy of stem cell-based therapies in cardiac tissue engineering and regenerative medicine.
